Finance
Markets
No recent trading data. The last price we hold for BAX is from Jun 3 (48 days ago). This symbol may be delisted, renamed, or halted — the figures below reflect its last active session, not the current market.

BAX

stock Healthcare Medical Instruments & Supplies
Baxter International
$18.54 -0.14 (-0.75%) Delayed · quoted 46d ago
Concerning 30% Slipping

What the indicators say

Mixed 3 of 5 trend signals bullish
Momentum · RSI 14 Neutral
53
0oversold 30overbought 70100

RSI 53 — momentum is balanced between buyers and sellers.

EMA 21 $18.40
Above
Near-term trend is up
SMA 50 $17.73
Above
Medium-term trend is up
SMA 200 $19.92
Below
Long-term trend is down
50 / 200-day
Death cross
50-day below the 200-day — bearish
Supertrend $17.50
Uptrend
Price is holding above the Supertrend band — bullish

A mechanical reading of the chart’s indicators — not investment advice.

Key statsas of Jun 3

The day open and close within the day's range
Low $18.42 High $18.86
Open
$18.55
-0.70%
Close
$18.55
-0.70%
52-week range where the price sits across its year
52w low $15.73 52w high $32.04
Current
$18.55
Prev close
$18.68
Volume 0.45× the 3-month average
0 avg 2× avg
Today
3.63M
3-mo avg
8.12M

Earningscalendar synced from Yahoo 57d ago

Most recent
Apr 3082 days ago
Next expected
Jul 30in 9 days

Recent earnings dates

  • Apr 30 82 days ago
  • Feb 12 159 days ago
  • Oct 30, 2025 264 days ago
  • Jul 31, 2025 355 days ago

Past earnings dates come from BAX’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.

Fundamentalssynced from SEC 51d ago

Weak

Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), BAX’s fundamentals read as weak overall.

P/E ratio No data
—

Earnings per share were negative, so a P/E cannot be formed; the company was unprofitable over the period.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Strong
2.80%

A 2.8% yield is a healthy, generally sustainable level of cash income.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Weak
-8.5%

A -8.5% margin is thin; little of each revenue dollar survives as profit.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Weak
-15.6%

A -15.6% return on equity is weak; owners' capital is barely being put to work.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Weak
-4.8%

A -4.8% return on assets is low; the asset base is generating little profit.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity Weak
2.28

At 2.28, the company leans heavily on borrowing, which adds risk if results weaken.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Strong
2.31

At 2.31, short-term assets comfortably cover short-term bills.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Fair
+5.7%

Revenue grew 5.7% from the prior year: steady, modest expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth No data
—

The company was unprofitable in both years, so an earnings growth rate is not meaningful.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financialssynced from SEC 51d ago

FY2021FY2022FY2023FY2024FY2025
Revenue $12.1B$10.1B$10.4B$10.6B$11.2B
Net income $1.3B-$2.4B$2.7B-$649.0M-$957.0M
Diluted EPS $2.53$-4.83$5.23$-1.27$-1.87
Dividend / share $1.08$1.15$1.16$1.04$0.52
Total assets $33.5B$28.3B$28.3B$25.8B$20.1B
Total liabilities $24.4B$22.4B$19.8B$18.8B$14.0B
Shareholder equity $9.1B$5.9B$8.5B$7.0B$6.1B

Leadershipsynced from SEC 58d ago

  • Hider Andrew P. President and CEO · Director
  • Grade Joel T. EVP and CFO
  • Carlisle Cynthia Executive Vice President, CHRO
  • Foster Julie President, Front Line Care
  • Rasul Reazur EVP,Group Pres,Healthcare
  • Rosenbloom David S. EVP and General Counsel
  • Soriano Maria Cecilia Group Pres., ITT & Pharma.
  • Teaff James President, CCS
  • Wallace Steven P. President, Adv. Surgery
  • Zielinski Anita A SVP, CAO and Controller
  • Ampofo William A. Ii Director
  • Craig Jeffrey A Director
  • Mcdonnell Michael R. Director
  • Morrison Patricia Director
  • Schlichting Nancy M Director
  • Shafer David Brent Director
  • Wendell Amy Mcbride Director
  • Wilkes David S. Director

Officers and board are drawn from BAX’s recent SEC ownership filings (Forms 3, 4 and 5).

Recent leadership changes

Notable recent eventspast year

Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.

Dividendssynced from Yahoo 52d ago

Pays quarterly Weak
2025 total
$0.52
2026 so far
$0.022 payments
2026 projected
$0.04-92.3% vs 2025

Projection scales BAX’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.

Payment history

  • May 29 $0.01
  • Feb 27 $0.01
  • Nov 28, 2025 $0.01
  • Aug 29, 2025 $0.17
  • May 30, 2025 $0.17
  • Feb 28, 2025 $0.17
  • Nov 29, 2024 $0.17
  • Aug 30, 2024 $0.29
  • May 31, 2024 $0.29
  • Feb 29, 2024 $0.29
  • Nov 30, 2023 $0.29
  • Aug 31, 2023 $0.29
  • Jun 1, 2023 $0.29
  • Feb 23, 2023 $0.29
  • Dec 1, 2022 $0.29
  • Sep 1, 2022 $0.29
  • Jun 2, 2022 $0.29
  • Feb 24, 2022 $0.28
  • Dec 2, 2021 $0.28
  • Sep 2, 2021 $0.28
  • Jun 3, 2021 $0.28

Recent SEC filingssynced from SEC 51d ago

© 2026 Isaac Bythewood · Some rights reserved